Agile Therapeutics reported 2.71M in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Adma Biologics ADMA:US $ 20.3M 1.46M
Agile Therapeutics AGRX:US 2.71M 1.57M
Bayer BAYN:GR € 3887M 659M
Biodelivery Sciences International BDSI:US $ 6.36M 2.08M
Biomarin Pharmaceutical BMRN:US $ 103.54M 23.52M
JAZZ PHA JAZZ:US $ 145.22M 26.03M
Johnson & Johnson JNJ:US $ 7250M 317M
Merk MRK:US $ 3056M 14M
Pacira Pharmaceuticals PCRX:US $ 34.65M 0.6M
Pfizer PFE:US $ 9931M 2939M
Teva Pharmaceutical Industries TEVA:US $ 1989M 2M
Therapeuticsmd TXMD:US 5.28M 1.15M